PLEURAL INFECTION
Clinical trials for PLEURAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new PLEURAL INFECTION trials appear
Sign up with your email to follow new studies for PLEURAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail could simplify treatment for dangerous lung lining infection
Disease control Recruiting nowThis study tests two different drug combinations for pleural infection, a serious infection of the lung lining that often requires surgery. The standard treatment uses two drugs (alteplase and DNase) given through a chest tube. This trial compares that to a new combination using …
Matched conditions: PLEURAL INFECTION
Sponsor: National University of Malaysia • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Saltwater rinse through chest tube may boost infection recovery
Symptom relief Recruiting nowThis study looks at whether adding a simple saltwater rinse (saline irrigation) through a chest tube can improve how well the standard medication clears a serious lung infection called empyema. About 60 adults with this infection will receive either standard treatment alone or st…
Matched conditions: PLEURAL INFECTION
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Flushing chest tubes may speed recovery from serious lung infections
Symptom relief Recruiting nowThis study looks at whether regularly flushing chest drains with salt water helps keep them from getting blocked in people with serious lung infections (empyema). The goal is to see if this simple step can shorten the time the drain needs to stay in, reduce hospital stays, and im…
Matched conditions: PLEURAL INFECTION
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could a lower dose of Clot-Buster be safer for lung infections?
Symptom relief Recruiting nowThis study tests whether a lower dose (2.5 mg) of a clot-busting drug called tPA works as well as the standard dose (10 mg) for treating pleural infections, which cause fluid buildup around the lungs. The drug is given through a chest tube along with another enzyme to help drain …
Matched conditions: PLEURAL INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC